FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav

[cafead]

via Jazz Pharmaceuticals PLC said on Thursday its sleep disorder drug Xywav received U.S. regulatory approval for the expanded use in patients suffering from excessive daytime sleepiness despite a good night's sleep.

article source